A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SRNS / steroid-resistant nephrotic syndrome

[Related PubMed/MEDLINE]
Total Number of Papers: 389
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SRNS  (>> Co-occurring Abbreviation)
Long Form:   steroid-resistant nephrotic syndrome
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene mutations: a systematic review. CNI
2020 Centromere protein I (CENPI) is a candidate gene for X-linked steroid sensitive nephrotic syndrome. CENPI, NS, SSNS
2020 COQ6 mutation in patients with nephrotic syndrome, sensorineural deafness, and optic atrophy. CoQ10
2020 Current understandings in treating children with steroid-resistant nephrotic syndrome. CNI
2020 Dyslipidemia and cardiovascular health in childhood nephrotic syndrome. ---
2020 Efficacy and safety of tacrolimus and low-dose prednisone in Chinese children with steroid-resistant nephrotic syndrome. ORR
2020 Generation of an induced pluripotent stem cell (iPSC) line (IMAGINi007) from a patient with steroid-resistant nephrotic syndrome carrying the homozygous p.R138Q mutation in the podocin-encoding NPHS2 gene. iPSC, PBMCs
2020 Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis. ESRD, FSGS
2020 Genetic Testing in Pediatric Kidney Disease. ---
10  2020 Genetic tests in children with steroid-resistant nephrotic syndrome. ---
11  2020 Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance. FSGS, MMP, NOX4, NS, ROS, STRA6
12  2020 IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. IPNA
13  2020 Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience. ---
14  2020 Pre-emptive rituximab and plasma exchange does not prevent disease recurrence following living donor renal transplantation in high-risk idiopathic SRNS. CR, DR, LD, PE, PR, RT
15  2020 Prevalence of the NPHS2 variants p.R229Q, p.A242V, and p.R138Q in patients with focal segmental glomerulosclerosis
16  2020 Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children. ---
17  2020 Treatment of nephrotic syndrome: going beyond immunosuppressive therapy. ---
18  2020 Two Children With Novel TRPC6 Spontaneous Missense Mutations and Atypical Phenotype: A Case Report and Literature Review. ESRD, FSGS, MGA
19  2020 Variations of type IV collagen-encoding genes in patients with histological diagnosis of focal segmental glomerulosclerosis. ESKD, FSGS, NGS
20  2019 -254C>G SNP in the TRPC6 Gene Promoter Influences Its Expression via Interaction with the NF-kappaB Subunit RELA in Steroid-Resistant Nephrotic Syndrome Children. ChIP-PCR, HEK, NF-kappaB, SNP, TNF-alpha, TRPC6
21  2019 A steroid-resistant nephrotic syndrome in an infant resulting from a consanguineous marriage with COQ2 and ARSB gene mutations: a case report. CKD, NS
22  2019 A Systematic Analysis of Major Susceptible Genes in Childhood-onset Steroid-resistant Nephrotic Syndrome. ---
23  2019 Altered B-Lymphocyte Homeostasis in Idiopathic Nephrotic Syndrome. INS, ROC, SSNS
24  2019 Analysis of NPHS2 Gene Mutations in Egyptian Children with Nephrotic Syndrome. SSNS
25  2019 APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries. APOL1, FSGS, HR, LR
26  2019 Association of low birth weight and prematurity with clinical outcomes of childhood nephrotic syndrome: a prospective cohort study. CI, HR, IQR, LBW, NBW, OR
27  2019 Corticosteroid treatment exacerbates nephrotic syndrome in a zebrafish model of magi2a knockout. ---
28  2019 Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children. FSGS, RCS, WES
29  2019 Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis. CR, CsA, CYC, P/NT, PR, TAC, TR
30  2019 Genetic spectrum of renal disease for 1001 Chinese children based on a multicenter registration system. CAKUT, CKD, TGS, WES
31  2019 Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how? ---
32  2019 Genetics of Childhood Steroid Sensitive Nephrotic Syndrome: An Update. SSNS
33  2019 Hypertension in Childhood Nephrotic Syndrome. CIMT, HTN, LVH, PWV, SSNS
34  2019 Idiopathic nephrotic syndrome and rituximab: may we predict circulating B lymphocytes recovery? RTX, SDNS
35  2019 Interventions for idiopathic steroid-resistant nephrotic syndrome in children. ACEI, ARB, CI, CNI, CPA, GFR, MD, MMF, RCTs, RR
36  2019 Intrinsic tumor necrosis factor-alpha pathway is activated in a subset of patients with focal segmental glomerulosclerosis. FSGS
37  2019 InVivo Expression of NUP93 and Its Alteration by NUP93 Mutations Causing Focal Segmental Glomerulosclerosis. CD2AP, ESRD, FSGS, NPCs
38  2019 Long-term outcome in a case series of Denys-Drash syndrome. DDS
39  2019 Molecular assay for an intronic variant in NUP93 that causes steroid resistant nephrotic syndrome. FSGS, NUP93
40  2019 Mutations in NUP160 Are Implicated in Steroid-Resistant Nephrotic Syndrome. Nup160
41  2019 Nephrotic state substantially enhances apparent mycophenolic acid clearance
42  2019 Pair analysis and custom array CGH can detect a small copy number variation in COQ6 gene. aCGH, CNVs, CoQ10, NGS
43  2019 Panel sequencing distinguishes monogenic forms of nephritis from nephrosis in children. aHUS, AS, CKD, WES
44  2019 Prevalence rates of histopathologic subtypes associated with steroid resistance in childhood nephrotic syndrome in Sub-Saharan Africa: a systematic review. FSGS, MCN, MesPGN, MN, MPGN, SSA
45  2019 Prospects of genetic testing for steroid-resistant nephrotic syndrome in Nigerian children: a narrative review of challenges and opportunities. FSGS, NHIS
46  2019 Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome. NS, P-gp, PBMCs, SSNS
47  2019 Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth. RTX, SSNS
48  2019 Sphingosine phosphate lyase insufficiency syndrome (SPLIS): A novel inborn error of sphingolipid metabolism. PAI, PE, S1P, S1PRs, SPL, SPLIS
49  2019 TBC1D8B Loss-of-Function Mutations Lead to X-Linked Nephrotic Syndrome via Defective Trafficking Pathways. FSGS
50  2019 TBC1D8B Mutations Implicate RAB11-Dependent Vesicular Trafficking in the Pathogenesis of Nephrotic Syndrome. ---
51  2019 The podocin V260E mutation predicts steroid resistant nephrotic syndrome in black South African children with focal segmental glomerulosclerosis. APOL1, FSGS, SSNS
52  2019 The podocin V260E mutation predicts steroid resistant nephrotic syndrome in black South African children with focal segmental glomerulosclerosis. APOL1, FSGS, SSNS
53  2019 Timing and predictive factors of developing chronic kidney disease in childhood-onset idiopathic nephrotic syndrome: an Asian experience. CI, CKD, HR, INS
54  2019 Treatment of steroid-resistant nephrotic syndrome in the genomic era. ---
55  2019 Treatment with 2,4-Dihydroxybenzoic Acid Prevents FSGS Progression and Renal Fibrosis in Podocyte-Specific Coq6 Knockout Mice. 2,4-diHB
56  2019 TRPC6 and NPHS2 gene variants in adult patients with steroid-resistant nephrotic syndrome in North-West of Iran. NS, PCR
57  2018 A homozygous KAT2B variant modulates the clinical phenotype of ADD3 deficiency in humans and flies. ---
58  2018 Analysis of 24 genes reveals a monogenic cause in 11.1% of cases with steroid-resistant nephrotic syndrome at a single center. BCH, ESRD
59  2018 Children with Steroid-Resistant Nephrotic Syndrome: A Single -Center Experience. CYC, ESRD, FSGS, MCNS, MMF, NS, RTX, UCCS, UCCT
60  2018 Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome. AR, SSNS
61  2018 Cyclophosphamide versus cyclosporine A therapy in steroid-resistant nephrotic syndrome: a retrospective study with a mean 5-year follow-up. CsA
62  2018 Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options. CNIs, FSGS, ISKDC, MCD, SSNS
63  2018 Effect of atorvastatin on dyslipidemia and carotid intima-media thickness in children with refractory nephrotic syndrome: a randomized controlled trial. CIMT, FMD, LDL-C
64  2018 Effect of Combined Gluten-Free, Dairy-Free Diet in Children With Steroid-Resistant Nephrotic Syndrome: An Open Pilot Trial. GF/DF
65  2018 Efficacy and Safety of Cyclosporine versus Tacrolimus in Steroid and Cyclophosphamide Resistant Nephrotic Syndrome: A Prospective Study. CNIs, CYC, TAC
66  2018 Exploring the Clinical and Genetic Spectrum of Steroid Resistant Nephrotic Syndrome: The PodoNet Registry. ---
67  2018 First Report of Recurrent Nephrotic Syndrome After Kidney Transplantation in a Patient With NUP93 Gene Mutations: A Case Report. FSGS, NS, NUP93, PE
68  2018 GAPVD1 and ANKFY1 Mutations Implicate RAB5 Regulation in Nephrotic Syndrome. ---
69  2018 Genetic diagnosis of steroid-resistant nephrotic syndrome in a longitudinal collection of Czech and Slovak patients: a high proportion of causative variants in NUP93. NGS
70  2018 Genetic mutation in Egyptian children with steroid-resistant nephrotic syndrome. ---
71  2018 Genetic Testing for Steroid-Resistant-Nephrotic Syndrome in an Outbred Population. ---
72  2018 Heterozygous COL4A3 Variants in Histologically Diagnosed Focal Segmental Glomerulosclerosis. FSGS
73  2018 HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome. SSNS
74  2018 Identification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults. FSGS
75  2018 Knockdown of NUP160 inhibits cell proliferation, induces apoptosis, autophagy and cell migration, and alters the expression and localization of podocyte associated molecules in mouse podocytes. shRNA
76  2018 Long-term clinicopathologic observation in a case of steroid-resistant nephrotic syndrome caused by a novel Crumbs homolog 2 mutation. CRB2, FSGS
77  2018 Management of steroid-resistant nephrotic syndrome in children and adolescents. ---
78  2018 Multicenter analysis of the efficacy and safety of a non-standard immunosuppressive therapy with rituximab in children with steroid-resistant nephrotic syndrome. RTX
79  2018 Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome. NPC
80  2018 Mycophenolate mofetil for sustained remission in nephrotic syndrome. FRNS, MMF, MPA, SDNS
81  2018 National survey found that managing childhood nephrotic syndrome in Nigeria varied widely and did not comply with the best evidence. ---
82  2018 Nephrological and urological complications of homozygous c.974G>A (p.Arg325Gln) OSGEP mutations. GAMOS, GFR, UTIs
83  2018 NPHS2 V260E Is a Frequent Cause of Steroid-Resistant Nephrotic Syndrome in Black South African Children. SA, SR-FSGS, SSNS
84  2018 Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings. FSGS, LSRNS, MCD, NS, PSRNS
85  2018 Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07). FRNS, INS, MMF, RTX, SDNS, SSNS
86  2018 Successful treatment of rituximab- and steroid-resistant nephrotic syndrome with leukocytapheresis. LCAP, RTX
87  2018 Targeted gene panel for genetic testing of south Indian children with steroid resistant nephrotic syndrome. NGS, VUS
88  2018 The clinical pattern of nephrotic syndrome in children has no effect on the concentration of soluble urokinase receptor (suPAR) in serum and urine. FSGS, SSNS, suPAR
89  2018 Treatment of Genetic Forms of Nephrotic Syndrome. CsA, FSGS
90  2018 Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome. FAC, NGS
91  2018 [Clinical analysis of one infantile nephrotic syndrome caused by COQ2 gene mutation and literature review]. ---
92  2018 [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome]. FRNS, FSGS, MsPGN
93  2017 A Novel Biomarker Panel to Identify Steroid Resistance in Childhood Idiopathic Nephrotic Syndrome. A1BG, AGP1, AGP2, AUCs, iTRAQ, NGAL, NS, SSNS, VDBP
94  2017 A Randomized Controlled Trial of Intravenous versus Oral Cyclophosphamide in Steroid-resistant Nephrotic Syndrome in Children. CR, IVCP, OCP, PR
95  2017 A small molecule screening to detect potential therapeutic targets in human podocytes. NCC, PMR
96  2017 Acute kidney injury in idiopathic nephrotic syndrome of childhood is a major risk factor for the development of chronic kidney disease. AKI, CKD, FSGS, INS
97  2017 Advillin acts upstream of phospholipase C ϵ1 in steroid-resistant nephrotic syndrome. AVIL, DAG, PMR
98  2017 Altered expression of Crb2 in podocytes expands a variation of CRB2 mutations in steroid-resistant nephrotic syndrome. ---
99  2017 Biochemical alteration in children with idiopathic nephrotic syndrome associated with an increased risk of sensorineural hearing loss; additional insights in cochlear renal relationship. INS, SDNS/FRNS, SNHL, SSNS
100  2017 Clinical genetic testing using a custom-designed steroid-resistant nephrotic syndrome gene panel: analysis and recommendations. AS, CNVs, NGS